@tferriss: “If some bullshit hype filters into this, it’s worth it in order to take the correct swings at the truly big ideas, bec…

X AI KOLs Following News
podcast genetic-medicine rna-therapeutics synthetic-biology tim-ferriss strand-therapeutics

Summary

This article announces Tim Ferriss's podcast episode featuring Jacob Becraft, CEO of Strand Therapeutics, discussing the revolution in genetic medicine and programmable RNA therapies.

“If some bullshit hype filters into this, it’s worth it in order to take the correct swings at the truly big ideas, because one out of 10 transformations is better than seven out of 10 logical steps forward.” — Jacob Becraft (@DrSynbio) Listen to my conversation with Jacob Becraft:
Original Article
View Cached Full Text

Cached at: 06/30/26, 01:47 PM

“If some bullshit hype filters into this, it’s worth it in order to take the correct swings at the truly big ideas, because one out of 10 transformations is better than seven out of 10 logical steps forward.” — Jacob Becraft (@DrSynbio)

Listen to my conversation with Jacob Becraft:

Tim’s Founder Kitchen — From Brainstorm to the President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics) (#868) - The Blog of Author Tim Ferriss

Source: https://tim.blog/2026/06/02/jake-becraft-strand-therapeutics/

“What I want the world to understand is that we are standing right now on the precipice of a revolution in genetic medicine.”— Jake Becraft

**Jake Becraft**is the CEO and co-founder ofStrand Therapeutics, a company building one of the most advanced programmable genetic medicine platforms in biotechnology. Under his leadership, Strand is redefining what RNA medicines can do by enabling cell-selective targeting and therapeutic payload delivery inside the body, unlocking a new class of precision genetic therapies. He has guided the company from its founding vision through platform development and into clinical translation, positioning Strand at the forefront of next generation RNA therapeutics.

Beyond his role at Strand, Dr. Becraft is an influential voice in the national biotechnology landscape. He engages and advises policymakers, defense leaders, and industry stakeholders on biosecurity, innovation strategy, and strengthening American competitiveness in advanced biotechnology. Trained as a synthetic biologist at MIT, he operates at the intersection of science, entrepreneurship, and policy, focused on building both the companies and the institutional frameworks required to secure the future of programmable medicine.

He received his Ph.D. in Biological Engineering and Synthetic Biology from MIT. He serves on the board of the Biotechnology Innovation Organization (BIO) and the Massachusetts Biotechnology Council (MassBio).

Please enjoy!

This episode is brought to you by:

  • Helix****Sleeppremium mattresses:HelixSleep.com/Tim(20% off any purchase)
  • Incogni, which automatically removes your personal data from the web, helping shield you from fraud, scams, and identity theft:Incogni.com/Tim(use code TIM at checkout and get 60% off an annual plan)

Tim’s Founder Kitchen — From Brainstorm to the President’s Office in Two Months (Featuring Jake Becraft, Strand Therapeutics)

Additional podcast platforms

Listen to this episode onApple Podcasts,Spotify,Overcast,Podcast Addict,Pocket Casts,Castbox,YouTube Music,Amazon Music,Audible, or on your favorite podcast platform.

Transcripts

SELECTED LINKS FROM THE EPISODE

  • Connect with Jacob Becraft:

Twitter|Strand Therapeutics

Books & Recommended Reading

Movies

Companies

Institutions & Organizations

Concepts & Therapies

People

Relevant Episodes

TIMESTAMPS

  • [00:00:00] Start.
  • [00:06:07] What Strand does.
  • [00:08:19] The Boston dinner.
  • [00:11:05] The image of a body riddled with cancer.
  • [00:15:05] What stuck for the muggles in the pitch deck.
  • [00:17:14] A good drug vs. a good product.
  • [00:19:40] Tricking cancer into snitching on itself.
  • [00:27:38] The abscopal effect.
  • [00:34:04] Potency, specificity, and delivery.
  • [00:35:46] First principles thinking.
  • [00:36:38] The precipice of a revolution.
  • [00:41:14] The thousand people in the room.
  • [00:48:38] Psychedelic medicine as a cautionary tale.
  • [00:51:17] What actually catches a policymaker’s attention.
  • [00:53:42] Breakthrough vs. incremental.
  • [00:54:55] What’s in it for the policymakers?
  • [00:58:08] The 80/20 wish list.
  • [01:01:31] Australia’s CTN system.
  • [01:03:51] Sheep, psychedelics, and red-tape arbitrage.
  • [01:05:22] China’s clinical-trial flywheel vs. slow-motion American loss.
  • [01:06:53] The bicoastal biotech ethos.
  • [01:08:10] Can the FDA actually pull this off?
  • [01:12:12] TheSophie’s Choiceof pharma development.
  • [01:14:16] Lost arts of founder mode.
  • [01:15:23] Rockets for tumors, T-cells, and beyond.
  • [01:19:16] Viral in policy circles.
  • [01:23:09] TheWashington Postheadline and the PickFu split test.
  • [01:27:56] Solution-first storytelling.
  • [01:33:54] RNA medicine and platform therapeutics.
  • [01:39:17] Moderna’s 62 days.
  • [01:40:33] Uber Eats and the de-risked launch.
  • [01:44:17] CEO blockers.
  • [01:45:52] Where’s biotech’s SpaceX moment?
  • [01:46:53] Elon Musk betting black on the wheel.
  • [01:51:55] AWS and the post-conviction / pre-consensus window.
  • [01:58:47] COVID politicization.
  • [01:59:46] Insulin, growth hormone, and the original platform story.
  • [02:01:35] Biotech as pharma’s little brother.
  • [02:03:29] More recent role models, Apple edition.
  • [02:04:50] Art Levinson, Steve Jobs, and the biotech-tech crossover.
  • [02:06:25] The iPhone as a delivery platform.
  • [02:08:25] Spotify’s problem and the future of bespoke medicine.
  • [02:10:07] Baby KJ and the limits of liver-only solutions.
  • [02:11:19] Parting thoughts.

JACOB BECRAFT QUOTES FROM THE INTERVIEW

“Our goal at Strand, and our challenge, is building drugs today that impact patients’ lives. We’re not a research institute. Our goal is not to do really cool research on mice and join the ranks of people who have cured mice of cancer. There’s millions of them. There could be a Nobel Prize every five minutes for someone who’s cured a mouse of cancer. Our goal is to cure human beings of human-being cancer. Our goal is to cure human beings of human-being diseases, and do so in a safe, effective, scalable way that impacts a person’s life as little as possible. And that is what we’re building.”

— Jacob Becraft

“What I want the world to understand is that we are standing right now on the precipice of a revolution in genetic medicine.”

— Jacob Becraft

“Everyone wants to cure cancer. I don’t need a story behind curing cancer. I just need a story about how we’re going to get there and how curing cancer is actually going to be one step on the road to solving disease writ large.”

— Jacob Becraft

“What we are in the midst of right now is the United States massively losing to China. China has built an industrialized version of clinical trial infrastructure for first-in-human trials that is so efficient and massively quick that they’re just able to go faster and cheaper into the thing that matters most, which is first-in-human trials. So the United States is actually in the process of very rapidly, as a country, falling behind China because what started as a place for American companies to come run clinical trials to get data and then take it to the FDA and then do larger trials in the United States has now created a flywheel structure within China where now just Chinese companies run their clinical trials faster than the American companies and then bring their Chinese-discovered drugs to the United States.”

— Jacob Becraft

“No one will learn until they care.”

— Jacob Becraft

“The biotechnology industry will be dragged kicking and screaming into the future, or it will be built up in a new way from new players.”

— Jacob Becraft

“If some bullshit hype filters into this, it’s worth it in order to take the correct swings at the truly big ideas, because one out of 10 transformations is better than seven out of 10 logical steps forward.”

— Jacob Becraft

“In low odds games, games where there’s a very low odds of success statistically, if you don’t go 100 percent all in, the odds will be zero.”

— Jacob Becraft

“When I look at some of those great investors who have made these high-conviction bets, it seems like they’re able to identify this moment in time for companies that is post-conviction, pre-consensus. The ones who know we’re post-conviction, we’re no longer saying, ‘Can we do this?’ We’re like, ‘Oh, my God, this is going to work.’ But it’s pre-consensus because not everyone has caught on yet or not everyone is convinced.”

— Jacob Becraft

**Want to hearanother episode with a physician-founder building a new class of medicine?**Listen tomy conversation with Dr. Kevin Tracey, president and CEO of the Feinstein Institutes for Medical Research, in which we discussed the birth of bioelectronic medicine, stimulating the vagus nerve to tame inflammation, the inflammatory reflex, treating rheumatoid arthritis and Crohn’s disease, SetPoint Medical’s FDA approval journey, alleviating depression and autoimmune disorders, building devices that replace drugs,and much more.

This episode is brought to you byIncogni: erase your personal data from the web and prevent scams, fraud, and identity theft!Incogniautomatically removes your information across 420+ data brokers (1,000+ additional sites covered in their Unlimited plan), and they keep it scrubbed automatically. Deloitte has independently verified the headline numbers (245M+ removal requests), and the company adheres to AICPA SOC security standards, with an A+ rating from the BBB. And with their Unlimited plan, if you find your info on a site they don’t automatically monitor, just send them the link, and their privacy team will handle it.​Protect yourself now with Incogni. Go to Incogni.com/Tim to get 60% off their annual plan.

**This episode is brought to you byHelix Sleep!**Helix was selected as the best overall mattress of 2025 byForbesandWiredmagazines and best in category byGood Housekeeping,GQ, and many others. WithHelix, there’s a specific mattress to meet each and every body’s unique comfort needs. Just take their quiz—only two minutes to complete—that matches your body type and sleep preferences to the perfect mattress for you. They have a 10-year warranty, and you get to try it out for a hundred nights, risk-free. They’ll even pick it up from you if you don’t love it.And now, Helix is offering listeners 20% off all mattress orders for a limited time atHelixSleep.com/Tim.

Similar Articles

The Download: coding’s future, the ‘Steroid Olympics,’ and AI-driven science

MIT Technology Review

MIT Technology Review's newsletter covers three major stories: Anthropic's Code with Claude event showing developers increasingly shipping AI-written code without review, the upcoming Enhanced Games for athletes using performance-enhancing drugs, and Google I/O's shift towards agentic AI for science with Gemini for Science.